Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HRH1 | P35367 | Histamine H1 receptor (H1-R) (H1R) (HH1R) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Clinical-translation mediationReceptor-signaling mediation | 6 | 0.63 | |||
| I12R1 | P42701 | Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| INSR | P06213 | Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] | CD markersDisease related genesEnzymes | 1 | Acute diabete complicationAlzheimer diseaseBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| ITB3 | P05106 | Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| JAM2 | P57087 | Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322) | 1 | Fusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Multiple myelomaMyelopathy | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| LAT | O43561 | Linker for activation of T-cells family member 1 (36 kDa phosphotyrosine adapter protein) (pp36) (p36-38) | Disease related genesHuman disease related genesPlasma proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | |||
| MMP15 | P51511 | Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2) | Cancer-related genesEnzymesPlasma proteins | 1 | Other mediation | 6 | 0.63 | |||
| NTR1 | P30989 | Neurotensin receptor type 1 (NT-R-1) (NTR1) (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH) | 7 | Acute/chronic painDissociative neurological symptom disorderIndeterminate colitis | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 6 | 0.63 | |||
| PCDGA | Q9Y5H3 | Protocadherin gamma-A10 (PCDH-gamma-A10) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 6 | 0.63 | |||
| PHAG1 | Q9NWQ8 | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp) | Predicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| PKD2 | Q13563 | Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2) | Disease related genesHuman disease related genesPlasma proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 6 | 0.63 | |||
| SL9A1 | P19634 | Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 13 | Angina pectorisCardiac arrhythmiaGenetic cardiac arrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4) | Disease related genesHuman disease related genesPotential drug targets | 6 | Fusion and delivery mediationImmune mediationMetabolism mediation | 6 | 0.63 | |||
| ICAM3 | P32942 | Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Immune mediation | 17 | 0.60 | |||
| NOTC2 | Q04721 | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Lung cancerPancreatic cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 16 | 0.60 | ||
| LIRB3 | O75022 | Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a) | 1 | Fusion and delivery mediationImmune mediation | 13 | 0.60 | ||||
| S43A3 | Q8NBI5 | Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 12 | Clinical-translation mediationFusion and delivery mediation | 13 | 0.60 | |||
| CLD23 | Q96B33 | Claudin-23 | 4 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 12 | 0.60 | ||||
| PCD17 | O14917 | Protocadherin-17 (Protocadherin-68) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 12 | 0.60 | |||
| DSC3 | Q14574 | Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationImmune mediation | 11 | 0.60 | |||
| TMM40 | Q8WWA1 | Transmembrane protein 40 | Predicted membrane proteins | 2 | Other mediation | 11 | 0.60 | |||
| HLAE | P13747 | HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)] | Plasma proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.50 | |||
| S39AA | Q9ULF5 | Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10) | Essential proteinsMetabolic proteinsPredicted intracellular proteins | 7 | Fusion and delivery mediationImmune mediation | 9 | 0.50 | |||
| ERBB2 | P04626 | Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.50 |